NCT06018194View on ClinicalTrials.gov

ELUCIDATE FFRct Study

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

ElucidVivo

Plaque morphology characterization on coronary CTA for predicting fractional flow reserve (FFRct)

Trial Locations (9)

22908

RECRUITING

University of Virginia, Charlottesville

30309

NOT_YET_RECRUITING

Piedmont Healthcare, Atlanta

37203

NOT_YET_RECRUITING

Centennial Heart, Nashville

37205

NOT_YET_RECRUITING

Ascension Medical Group, Nashville

44195

NOT_YET_RECRUITING

Cleveland Clinic, Cleveland

46845

NOT_YET_RECRUITING

Parkview Health, Fort Wayne

66211

RECRUITING

Midwest Heart and Vascular Specialists, Overland Park

90210

NOT_YET_RECRUITING

Cardiovascular Medical Group of Southern California, Beverly Hills

07450

NOT_YET_RECRUITING

Valley Health System, Ridgewood

All Listed Sponsors
collaborator

Lundquist Institute at Harbor-UCLA Medical Center

UNKNOWN

lead

Elucid Bioimaging Inc.

INDUSTRY